FESTUCCIA, MORENO BENEDETTO
 Distribuzione geografica
Continente #
NA - Nord America 3.868
EU - Europa 2.313
AS - Asia 1.571
SA - Sud America 122
OC - Oceania 76
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 10
Totale 8.004
Nazione #
US - Stati Uniti d'America 3.699
CN - Cina 831
DE - Germania 626
IT - Italia 529
JP - Giappone 231
GB - Regno Unito 196
CA - Canada 153
ES - Italia 147
FR - Francia 139
KR - Corea 107
IN - India 103
AT - Austria 95
PL - Polonia 87
VN - Vietnam 70
AU - Australia 67
RO - Romania 67
TR - Turchia 56
IE - Irlanda 55
RU - Federazione Russa 55
NL - Olanda 54
BR - Brasile 52
BE - Belgio 36
SE - Svezia 35
CO - Colombia 34
ZA - Sudafrica 32
CZ - Repubblica Ceca 29
HK - Hong Kong 25
IL - Israele 24
TW - Taiwan 24
CH - Svizzera 23
GR - Grecia 22
MY - Malesia 22
HU - Ungheria 21
PT - Portogallo 16
DK - Danimarca 15
MX - Messico 15
AR - Argentina 14
SG - Singapore 13
CL - Cile 12
UA - Ucraina 12
ID - Indonesia 11
IQ - Iraq 11
LT - Lituania 11
TH - Thailandia 10
FI - Finlandia 9
NZ - Nuova Zelanda 9
PE - Perù 8
BY - Bielorussia 7
IR - Iran 7
BG - Bulgaria 6
PK - Pakistan 6
SA - Arabia Saudita 6
EU - Europa 5
AP - ???statistics.table.value.countryCode.AP??? 4
MK - Macedonia 4
NO - Norvegia 4
HR - Croazia 3
MA - Marocco 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
BD - Bangladesh 2
CY - Cipro 2
EC - Ecuador 2
EG - Egitto 2
LB - Libano 2
LU - Lussemburgo 2
PH - Filippine 2
RS - Serbia 2
SD - Sudan 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BH - Bahrain 1
CR - Costa Rica 1
EE - Estonia 1
IS - Islanda 1
JO - Giordania 1
LK - Sri Lanka 1
QA - Qatar 1
SI - Slovenia 1
YE - Yemen 1
Totale 8.004
Città #
Fairfield 355
Houston 308
Buffalo 212
Woodbridge 212
Ann Arbor 195
Seattle 167
Ashburn 164
Santa Cruz 164
Beijing 153
Cambridge 149
Wilmington 130
Shanghai 123
Torino 91
Tokyo 76
Vienna 76
Dong Ket 59
Warsaw 57
Pisa 54
Wuhan 53
Ottawa 51
Dublin 50
University Park 50
Mariano Comense 46
New York 44
Guangzhou 42
Hangzhou 39
Nürnberg 38
Chengdu 37
Madrid 34
San Diego 33
Nanjing 32
Bengaluru 27
Chicago 27
Toronto 26
Las Vegas 25
Clearwater 24
Muizenberg 24
London 22
Milan 22
Phoenix 22
Los Angeles 21
Seoul 21
Rochester 20
Rome 20
Jinan 19
Mountain View 18
Tianjin 18
Istanbul 17
Taipei 17
Dallas 15
Budapest 14
Duncan 14
Lake Forest 14
Osaka 14
Fuzhou 13
Hefei 13
Madison 13
Paris 13
Xian 13
Baltimore 12
Boston 12
Hebei 12
Redmond 12
Saint Louis 12
Salt Lake City 12
San Francisco 12
São Paulo 12
Bogotá 11
Changsha 11
Leawood 11
Norwalk 11
Washington 11
Ankara 10
Athens 10
Denver 10
Geretsried 10
Moscow 10
Berlin 9
Brescia 9
Collegeville 9
Easton 9
Essen 9
Hyderabad 9
Kota Bharu 9
Medellín 9
North Wales 9
Philadelphia 9
Riva 9
Zhengzhou 9
Birmingham 8
Bologna 8
Durham 8
Jakarta 8
Lima 8
Munich 8
Princeton 8
Provo 8
Singapore 8
Vigo 8
Atlanta 7
Totale 4.216
Nome #
Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation, file e27ce428-a144-2581-e053-d805fe0acbaa 1.977
Extracellular vesicles as potential biomarkers of acute graft-vs.-host-disease, file e27ce42b-fd78-2581-e053-d805fe0acbaa 665
Immuno-oncologic Approaches: CAR-T Cells and Checkpoint Inhibitors, file e27ce42c-b4b4-2581-e053-d805fe0acbaa 658
Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugs., file e27ce428-b439-2581-e053-d805fe0acbaa 624
Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting), file e27ce428-a310-2581-e053-d805fe0acbaa 448
Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation, file e27ce42c-0540-2581-e053-d805fe0acbaa 408
Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma., file e27ce426-fca2-2581-e053-d805fe0acbaa 395
Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma, file e27ce427-77e8-2581-e053-d805fe0acbaa 344
Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients, file e27ce42d-4424-2581-e053-d805fe0acbaa 243
Allogeneic Stem Cell Transplantation in Multiple Myeloma Relapsed after Autograft: A Multicenter Retrospective Study Based on Donor Availability., file e27ce426-ce61-2581-e053-d805fe0acbaa 241
CLINICAL IMPACT OF IMMUNOPHENOTYPIC REMISSION AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN MULTIPLE MYELOMA, file e27ce427-4c29-2581-e053-d805fe0acbaa 205
Trichoderma species fungemia after high-dose chemotherapy and autologous stem cell transplantation: a case report, file e27ce428-b44a-2581-e053-d805fe0acbaa 192
Recurrent plasmacytomas after allografting in a patient with multiple myeloma., file e27ce426-fff4-2581-e053-d805fe0acbaa 190
High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma, file e27ce426-ff25-2581-e053-d805fe0acbaa 179
Restoring natural killer cell immunity against multiple myeloma in the era of new drugs, file e27ce42c-a9c6-2581-e053-d805fe0acbaa 176
Prospective molecular monitoring of minimal residual disease after nonmyeloablative allografting in newly diagnosed multiple myeloma, file e27ce427-4b8d-2581-e053-d805fe0acbaa 165
Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation., file e27ce42c-32ce-2581-e053-d805fe0acbaa 161
Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the italian bone marrow donor registry., file e27ce426-fffb-2581-e053-d805fe0acbaa 151
Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma, file e27ce42c-91d4-2581-e053-d805fe0acbaa 137
IMMUNOPHENOTYPIC RESPONSE AFTER ALLOGRAFTING IN MULTIPLE MYELOMA, file e27ce427-0a2b-2581-e053-d805fe0acbaa 135
Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma, file e27ce42c-7b37-2581-e053-d805fe0acbaa 128
Late-Onset Hepatic Veno-Occlusive Disease after Allografting: Report of Two Cases with Atypical Clinical Features Successfully Treated with Defibrotide, file e27ce42c-5ec5-2581-e053-d805fe0acbaa 124
Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation, file e27ce42d-4428-2581-e053-d805fe0acbaa 90
IMMUNOPHENOTYPIC RESPONSE AFTER ALLOGRAFTING IN MULTIPLE MYELOMA, file e27ce427-0a2d-2581-e053-d805fe0acbaa 82
High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma, file e27ce427-0a2c-2581-e053-d805fe0acbaa 76
Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation, file e27ce432-4ba4-2581-e053-d805fe0acbaa 36
ROLE OF ALLOGRAFTING IN HIGH RISK ACUTE MYELOID LEUKEMIA, file e27ce426-ff24-2581-e053-d805fe0acbaa 31
ROLE OF ALLOGRAFTING IN ACUTE LYMPHOBLASTIC LEUKEMIA: A 12 YEAR EXPERIENCE, file e27ce427-0a2a-2581-e053-d805fe0acbaa 25
Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma, file e27ce42c-9e99-2581-e053-d805fe0acbaa 24
Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting, file e27ce42d-4426-2581-e053-d805fe0acbaa 14
Extracellular vesicles as potential biomarkers of acute graft-vs.-host-disease, file e27ce432-5b20-2581-e053-d805fe0acbaa 5
Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting, file e27ce42e-38b6-2581-e053-d805fe0acbaa 3
Current use and potential role of procalcitonin in the diagnostic work up and follow up of febrile neutropenia in hematological patients, file e27ce42c-2944-2581-e053-d805fe0acbaa 1
Totale 8.333
Categoria #
all - tutte 9.526
article - articoli 0
book - libri 0
conference - conferenze 899
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.425


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019554 0 0 0 0 0 0 0 0 0 157 232 165
2019/20201.621 141 151 108 211 143 127 124 115 155 94 135 117
2020/20211.649 121 123 133 110 133 230 95 135 116 146 151 156
2021/20221.803 183 120 125 273 216 107 144 92 108 74 238 123
2022/2023870 32 86 212 144 82 56 74 47 50 72 15 0
2023/202430 3 1 3 8 3 1 2 6 2 1 0 0
Totale 8.333